Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

ABT Abbott Laboratories
$107.28 -1.17% -1.27
Notify me if price changes either direction
Interactive Brokers Logotype

Buy ABT stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 189.3B
Enterprise value 194.7B
Trailing PE 29.239246
Forward PE 17.451868
PEG Ratio -0.36171204244365
Enterprise to EBITDA 16.94
Enterprise to revenue 4.392
Price to book MRQ 3.7119067
Price to sales TTM 4.2706575

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2025-12-31
Revenue (TTM) 44.3B
EBITDA 11.5B
Diluted EPS TTM 3.72
Total Cash (MRQ) 7.7B
Current ratio (MRQ) 1.7034014538472
Operating Cash Flow (TTM) 16.9B

ABT trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent ABT News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.